Skip to main content

Table 1 Correlation of clinic-pathological features with LAD1 expression in NSCLC TMA cohort

From: circ-ANXA7 facilitates lung adenocarcinoma progression via miR-331/LAD1 axis

Variables Clinicopathological features LAD1 expression  
Low expression (n = 53) High expression (n = 42) p-value
Age (years) ≤ 65 23 (43.4%) 23 (54.8%) 0.371
  > 65 30 (56.6%) 19 (45.2%)  
Gender Male 35 (66.0%) 23 (54.8%) 0.364
  Female 18 (34.0%) 19 (45.2%)  
Smoking history Smokers 38 (71.7%) 24 (57.1%) 0.207
  Never smokers 15 (28.3%) 18 (42.9%)  
Histologic subtype Squamous cell carcinoma 17 (32.1%) 20 (47.6%) 0.183
  Adenocarcinoma 36 (67.9%) 22 (52.4%)  
TNM stage Stage I & II 44 (83.0%) 26 (61.9%) 0.020
  Stage III 9 (16.9%) 16 (38.0%)  
Tumor size (cm) ≤ 5 45 (84.9%) 25 (59.5%) 0.001***
  > 5 8 (15.1%) 17 (40.5%)  
Lymph metastasis No 42 (79.2%) 23 (54.8%) 0.02*
  Yes 11 (20.8%) 19 (45.2%)  
Recurrence status No 41 (77.4 %) 15 (35.7 %) < 0.0001****
  Yes 12 (22.6 %) 27 (64.3 %)  
  1. *p < 0.05; ***p < 0.001; ****p < 0.0001